A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2002
11/13/2002	EP0777477B1 Improved pharmaceutical formulations containing ibuprofen and codeine
11/13/2002	EP0735863B1 Accelerated release composition containing bromocriptine
11/13/2002	EP0693935B1 Method and compositions for digesting tissue
11/13/2002	EP0618807B1 A stabilized pharmaceutical formulation comprising growth hormone and histidine
11/13/2002	CN1379785A Caspase inhibitors for treatment and prevention of chemotherapy and radiation therapy induced cell death
11/13/2002	CN1379769A Novel composition and method or stabilizing same
11/13/2002	CN1379768A Improved aqueous solubility pharmaceutical formulations
11/13/2002	CN1379683A 疫苗 Vaccine
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use
11/13/2002	CN1379678A Method for calming human beings using personal care compositions
11/13/2002	CN1379677A Method of preventing adhesions with absorbable polyoxaesters
11/13/2002	CN1379676A Blood plasma replacement composition
11/13/2002	CN1379674A Ciclesonide contained pharmaceutical composition for application to mucosa
11/13/2002	CN1379673A Ciclesonide-containing aqueous pharmaceutical composition
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379667A Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use
11/13/2002	CN1379665A Method for delivering benzidine prostaglandins by inhalation
11/13/2002	CN1379663A Vaccine composition and method of using same
11/13/2002	CN1379623A Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
11/13/2002	CN1379149A Weight-lossing fabric and its preparing process
11/13/2002	CN1379146A Anticoagulation antibacterial non-woven cloth containing nano silver (Ag+Ag2O) and its industrial production technology
11/13/2002	CN1379080A Process for extracting and refining fox oil and its application in exterior-applied ointment
11/13/2002	CN1379068A Low foaming N-alkyl-tartraimine and N-alkyl melicimine wetting agent
11/13/2002	CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process
11/13/2002	CN1379040A Soluble inorganic salt of Huanweihuangyangxing D, its preparing process and medicine containing it
11/13/2002	CN1378859A Antalgic medicine for cancerous pain and its preparing process
11/13/2002	CN1378852A Detoxicating ointment for treating burn and scald and its preparing process
11/13/2002	CN1378847A 鲨鱼软骨胶囊 Shark Cartilage Capsules
11/13/2002	CN1378846A Shark-liver oil softgel
11/13/2002	CN1378843A Ursine seal fat softgel
11/13/2002	CN1378842A Ointment for treating dermatopathy
11/13/2002	CN1378840A Slow-releasing composition of estrogen medicine and its preparing process
11/13/2002	CN1094061C Medicine for curing appendicities and its preparing method
11/12/2002	US6479692 Reacting a keto-carboxy derivative with a substituted aniline to form an amide and treating to form an acylanilide
11/12/2002	US6479649 Subjecting carrageenan-containing seaweed material having solids content of less than 25% by weight to shear stress treatment; for foods, dairy products, toothpaste
11/12/2002	US6479627 Aqueous preparation of lactoferrin having improved stability
11/12/2002	US6479556 Adding polyoxyethylene sorbitan ester to an ophthalmic formulation containing a terpenoid such as camphor, borneol, and menthol to improve wettability
11/12/2002	US6479551 Treatment of migraine headache
11/12/2002	US6479545 Formulation for menopausal women
11/12/2002	US6479541 Amiodarone-containing parenteral administration
11/12/2002	US6479540 Compositions of tocol-soluble therapeutics
11/12/2002	US6479533 Methods and compositions for the protection of mitochondria
11/12/2002	US6479496 Treating a human patient suffering from variant and exercise-induced angina by administering a sustained release pharmaceutical dosage form including at least 50% by weight ranolazine in no more than two tablets per dose
11/12/2002	US6479473 Long-acting antimicrobials
11/12/2002	US6479283 Stimulation, culture and preservation of pancreatic cells
11/12/2002	US6479146 Preparing coated capsules and hollow shells by coating colloidal particles with alternating layers of oppositely charged nanoparticles and polyelectrolytes
11/12/2002	US6479078 Substantially crystalline form of melagatran
11/12/2002	US6479076 Nicotine delivery compositions
11/12/2002	US6479075 Pharmaceutical formulations for acid labile substances
11/12/2002	US6479071 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
11/12/2002	US6479067 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
11/12/2002	US6479066 Device having a microporous membrane lined deformable wall for implanting cell cultures
11/12/2002	US6479065 Process for the preparation of polymer-based sustained release compositions
11/12/2002	US6479060 Elegant hydrogenated castor oil ointments
11/12/2002	US6479058 Composition for the topical treatment of poison ivy and other forms of contact dermatitis
11/12/2002	US6479052 Spray delivery of cells
11/12/2002	US6479049 Methods and compositions for the dry powder formulation of interferons
11/12/2002	US6479048 Foam inhibitor comprising hydrophobic amino acid which is suitable for inhibiting foaming induced when dissolving a dry composition containing saccharide; preferably has a hydropathy index of not less than 2.
11/12/2002	US6479045 Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
11/12/2002	US6479042 Reducing agent with several constituents comprising at least a composition in powder form containing an agent for reducing hair sulphur bonds and method for permanent setting of keratin fibres
11/12/2002	US6479041 Method for producing aqueous emulsions or suspensions
11/12/2002	US6479039 Antimicrobial artificial nail composition and methods for preparing and using same
11/12/2002	US6479035 Pharmaceutical formulation of fluticasone propionate
11/12/2002	US6479034 Method of preparing gas and gaseous precursor-filled microspheres
11/12/2002	CA2266478C Polymerizable biodegradable polymers including carbonate or dioxanone linkages
11/12/2002	CA2204789C Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
11/12/2002	CA2204535C Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/12/2002	CA2195318C Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2110162C Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally
11/12/2002	CA2088289C Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same
11/12/2002	CA2071518C Oral composition for the treatment of inflammatory bowel diseases
11/12/2002	CA2049668C Bioerodible implants
11/12/2002	CA2038637C Pharmaceutical iodine compositions
11/12/2002	CA2009533C Novel cyclosporin galenic forms
11/11/2002	CA2385510A1 Use of hydroxyflavanones for masking bitter taste
11/07/2002	WO2002088666A2 Method for identifying lymph nodes
11/07/2002	WO2002088664A2 Control of compactability through crystallization
11/07/2002	WO2002088374A1 Process for producing isomaltose and use thereof
11/07/2002	WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	WO2002088246A1 Molded object having high pullulan content, process for producing the same, and use thereof
11/07/2002	WO2002088167A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002	WO2002088070A1 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
11/07/2002	WO2002087747A1 Stable aqueous colloidal dispersion, method for preparing same
11/07/2002	WO2002087737A1 Deagglomerator apparatus and method
11/07/2002	WO2002087645A1 Hydrogel compositions
11/07/2002	WO2002087642A2 Two-phase, water-absorbent bioadhesive composition
11/07/2002	WO2002087623A1 Microparticle protection of therapeutic agents
11/07/2002	WO2002087622A1 Oral preparations and supports for oral preparations
11/07/2002	WO2002087621A1 Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
11/07/2002	WO2002087616A1 Preventives for postoperative recurrence of premenopausal breast cancer
11/07/2002	WO2002087614A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002	WO2002087603A1 Immunopotentiators
11/07/2002	WO2002087602A1 Granulated product and process for producing tablets
11/07/2002	WO2002087600A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit
11/07/2002	WO2002087596A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/07/2002	WO2002087592A1 Injectable pamidronate disodium
11/07/2002	WO2002087588A1 Amorphous cefditoren pivoxil composition and process for producing the same
11/07/2002	WO2002087586A1 Sustained release drug delivery system containing codrugs
11/07/2002	WO2002087582A1 Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids

1 ... 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 ... 2991